Dr. Hann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
- University of ChicagoResidency, Internal Medicine, 2000 - 2002
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2000
Certifications & Licensure
- MD State Medical License 2003 - 2024
- NC State Medical License 2020 - 2022
- IL State Medical License 2000 - 2003
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer Start of enrollment: 2012 Jun 01
- Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2012 Sep 28
- Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer Start of enrollment: 2016 Jan 25
- Join now to see all
Publications & Presentations
PubMed
- Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLC.Mari Nakazawa, Guilherme Harada, Paola Ghanem, Adrian Bubie, Lesli A Kiedrowski, Joseph C Murray, Kristen A Marrone, Susan C Scott, Stefanie Houseknecht, Christina J F...> ;Cancer Research Communications. 2024 Mar 14
- 2 citationsElucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.Murray, J., Sivapalan, L., Hummelink, K., Balan, A., White, J., Niknafs, N., Rhymee, L., Pereira, G., Rao, N., Weksler, B., Bahary, N., Phallen, J., Leal, A., Bartlett...> ;Clinical Cancer Research. 2024 Jan 17
- Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non-Small-Cell Lung Cancer.Paola Ghanem, Joseph C Murray, Melinda Hsu, Matthew Z Guo, David S Ettinger, Josephine Feliciano, Patrick Forde, Christine L Hann, Vincent K Lam, Benjamin Levy, Valsam...> ;Clinical Lung Cancer. 2024 Mar 1
- Join now to see all
Press Mentions
- OncLive® Presents the Latest State of the Science Summit™ on Advances in Lung Cancer ManagementOctober 29th, 2018
Professional Memberships
- Member
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
- Johns Hopkins Bayview Medical CenterBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/christine-hann
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: